- Reported result:
- Billions in R&D and admin spending Cost Savings
- Deployment timeframe:
- Not reported by source
- Technology:
- Large Language Models & Generative AI
- Vendor:
- Not available in record
Large Language Models & Generative AI in Pharmaceutical & Life Science
Explore 19 documented Large Language Models & Generative AI deployments in Pharmaceutical & Life Science. These source-extracted records passed the automated evidence gate; that is not independent fact verification.
This evidence set isolates Large Language Models & Generative AI deployments within Pharmaceutical & Life Science. The records below identify the implementing organization, technology and vendor when reported, source-reported results, cited source, and missing evidence explicitly.
Documented Large Language Models & Generative AI implementations in Pharmaceutical & Life Science
Pharmaceutical companies (unnamed, via Accenture)
Pharmaceutical companies cut CTD authoring time 60–65% with Accenture's AWS generative AI solution
- Reported result:
- 60–65% CTD Authoring Time Reduction
- Deployment timeframe:
- Not reported by source
- Technology:
- Large Language Models & Generative AI
- Vendor:
- Not available in record
Undisclosed Top-10 Global Pharma
Top-10 Global Pharma Reduces Regulatory Submission Drafting Time by 75%+ with IBM Multi-Agent AI
- Reported result:
- Up to 75% Regulatory Submission Turnaround Acceleration
- Deployment timeframe:
- Not reported by source
- Technology:
- Large Language Models & Generative AI
- Vendor:
- Not available in record
Unnamed Global Pharmaceutical Company
Agentic AI cuts clinical trial protocol development from 6 months at global pharma company
- Reported result:
- Reduced from up to 6 months Clinical Trial Protocol Timeline
- Deployment timeframe:
- Not reported by source
- Technology:
- Large Language Models & Generative AI
- Vendor:
- Not available in record
- Reported result:
- 269 days (vs. 8-10 year typical) COVID-19 Vaccine Development Time
- Deployment timeframe:
- Not reported by source
- Technology:
- Large Language Models & Generative AI
- Vendor:
- Not available in record
Insilico Medicine
Insilico Medicine's AI-generated drug INS018_055 enters Phase II human clinical trials for idiopathic pulmonary fibrosis
- Reported result:
- ~3 years (2020 discovery to 2023 Phase II) Drug Development Timeline to Phase II
- Deployment timeframe:
- Not reported by source
- Technology:
- Large Language Models & Generative AI
- Vendor:
- Not available in record
- Reported result:
- 50,000+ employees (67% of workforce) Active Monthly Users
- Deployment timeframe:
- Not reported by source
- Technology:
- Large Language Models & Generative AI
- Vendor:
- Not available in record
Bristol Myers Squibb
Bristol Myers Squibb accelerates clinical trial timelines by months with Workbench generative AI platform
- Reported result:
- Under 100 to nearly 900 users in 3 months Platform User Growth
- Deployment timeframe:
- Not reported by source
- Technology:
- Large Language Models & Generative AI
- Vendor:
- Not available in record
Insilico Medicine
Insilico Medicine discovers IPF drug candidate ISM001-055 in 18 months for $2M using generative AI
- Reported result:
- 18 months Time to Phase 1 Readiness
- Deployment timeframe:
- Not reported by source
- Technology:
- Large Language Models & Generative AI
- Vendor:
- Insilico Medicine
Insilico Medicine
Insilico Medicine's Generative AI Platform Designs TNIK Inhibitor That Achieves Positive Phase 2a Results for IPF in 18-Month Discovery Timeline
- Reported result:
- +98.4 mL vs. –62.3 mL FVC Improvement vs. Placebo (60mg dose)
- Deployment timeframe:
- Not reported by source
- Technology:
- Large Language Models & Generative AI
- Vendor:
- Not available in record
Insilico Medicine
Insilico Medicine reaches Phase 2a clinical milestone with generative AI-designed TNIK inhibitor for IPF in under 30 months
- Reported result:
- Under 30 months Time to Phase 1 Clinical Success
- Deployment timeframe:
- Not reported by source
- Technology:
- Large Language Models & Generative AI
- Vendor:
- Not available in record
AstraZeneca
AstraZeneca cuts protocol authoring time 85% with Modella AI multimodal models in oncology R&D
- Reported result:
- 85% Protocol Authoring Time Reduction
- Deployment timeframe:
- Not reported by source
- Technology:
- Large Language Models & Generative AI
- Vendor:
- Not available in record
- Reported result:
- 16,000 hours Scientist Search Time Saved Annually
- Deployment timeframe:
- Not reported by source
- Technology:
- Large Language Models & Generative AI
- Vendor:
- Not available in record
Merck
Merck cuts clinical study report drafting from 3 weeks to 4 days with LLM-powered authoring platform
- Reported result:
- 180 hours to 80 hours CSR Draft Time Reduction
- Deployment timeframe:
- Not reported by source
- Technology:
- Large Language Models & Generative AI
- Vendor:
- Not available in record
National Institutes of Health (NIH) / National Library of Medicine
NIH's TrialGPT cuts clinical trial patient screening time by 40% using large language models
- Reported result:
- 40% Patient Screening Time Reduction
- Deployment timeframe:
- Not reported by source
- Technology:
- Large Language Models & Generative AI
- Vendor:
- Not available in record
Insilico Medicine
Insilico Medicine cuts drug discovery timeline to 12-18 months with generative AI platform Chemistry42, advancing ISM3412 cancer drug to Phase 1 trial
- Reported result:
- 12–18 months (vs. 2.5–4 years traditional) Discovery Timeline (project initiation to PCC)
- Deployment timeframe:
- Not reported by source
- Technology:
- Large Language Models & Generative AI
- Vendor:
- Not available in record
Bristol Myers Squibb
Bristol Myers Squibb accelerates clinical trials by months with Workbench AI platform
- Reported result:
- Under 100 to nearly 900 users in 3 months User Adoption Growth
- Deployment timeframe:
- Not reported by source
- Technology:
- Large Language Models & Generative AI
- Vendor:
- Not available in record
Novo Nordisk
Novo Nordisk cuts clinical study report generation time by 90% with generative AI on AWS
- Reported result:
- 90% Documentation Time Reduction
- Deployment timeframe:
- Not reported by source
- Technology:
- Large Language Models & Generative AI
- Vendor:
- Not available in record
Bristol Myers Squibb
Bristol Myers Squibb accelerates drug development pipeline with Accenture GenAI
- Reported result:
- Drug Development Pipeline Focus Area
- Deployment timeframe:
- Not reported by source
- Technology:
- Large Language Models & Generative AI
- Vendor:
- Not available in record